A number of studies in 2014 have enhanced our knowledge of the pathophysiology of hypertension, including the effects of a low-salt diet, hypertension in resource-poor countries, hypoxia-induced blood pressure elevation, antihypertensive therapies, the therapeutic role of renal denervation, and the effect of cardiovascular risk on adverse outcomes in patients with hypertension.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1038%2Fnrcardio.2014.221/MediaObjects/41569_2015_Article_BFnrcardio2014221_Fig1_HTML.jpg)
References
He, F. J., Pombo-Rodrigues, S. & MacGregor, G. A. Salt reduction in England from 2003 to 2011: its relationship to blood pressure, stroke and ischaemic heart disease mortality. BMJ Open 4, e004549 (2014).
Lloyd-Sherlock, P., Beard, J., Minicuci, N., Ebrahim, S. & Chatterji, S. Hypertension among older adults in lowand middle-income countries: prevalence, awareness and control. Int. J. Epidemiol. 43, 116–128 (2014).
Parati, G. et al. Changes in 24 h ambulatory blood pressure and effects of angiotensin II receptor blockade during acute and prolonged high-altitude exposure: a randomized clinical trial. Eur. Heart J. http://dx.doi.org/10.1093/eurheartj/ehu275.
Krum, H. et al. Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study. Lancet 383, 622–629 (2014).
Schirmer, S. H. et al. Improvements in left ventricular hypertrophy and diastolic function following renal denervation: effects beyond blood pressure and heart rate reduction. J. Am. Coll. Cardiol. 63, 1916–1923 (2014).
Bhatt, D. L. et al. A controlled trial of renal denervation for resistant hypertension. N. Engl. J. Med. 370, 1393–1401 (2014).
Thomopoulos, C., Parati, G. & Zanchetti, A. Effects of blood pressure lowering on outcome incidence in hypertension: 3. Effects in patients at different levels of cardiovascular risk- overview and meta-analyses of randomized trials. J. Hypertens. 32, 2305–2314 (2014).
Thomopoulos, C., Parati, G. & Zanchetti, A. Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials. J. Hypertens. 32, 2285–2295 (2014).
Thomopoulos, C., Parati, G. & Zanchetti, A. Effects of blood pressure lowering on outcome incidence in hypertension: 2. Effects at different baseline and achieved blood pressure levels —overview and meta-analyses of randomized trials. J. Hypertens. 32, 2296–2304 (2014).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Parati, G. Linking pathophysiology to antihypertensive treatment. Nat Rev Cardiol 12, 77–79 (2015). https://doi.org/10.1038/nrcardio.2014.221
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrcardio.2014.221
This article is cited by
-
Neuroimmune crosstalk in the pathophysiology of hypertension
Nature Reviews Cardiology (2019)